EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Addressing the Diabetes Tsunami Requires Expanded Access to Diabetes Technologies

Davida F Kruger, Christopher G Parkin iD, Irl B Hirsch iD, Grazia Aleppo iD, Janet B McGill, Rodolfo J Galindo iD, Carol J Levy iD, Guillermo E Umpierrez iD, George Grunberger, Richard M Bergenstal iD

Journal of Diabetes Science and Technology · 2026

DOI: 10.1177/19322968251332956 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Diabetes Science and Technology, 2026. Verfasst von Davida F Kruger und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes, Bone & Mineral, Henry Ford Health System, Detroit, MI, USA. Hauptthemen laut MEDLINE: Insulin Infusion Systems, Insulin, Diabetes Mellitus, Hypoglycemic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The use of continuous glucose monitoring (CGM) and automated insulin delivery (AID) technologies can improve patient outcomes and overall quality of life while helping to reduce the long-term costs. However, current eligibility criteria imposed by many major commercial insurers limit access to these technologies among a large portion of the diabetes population. This narrative review and commentary highlights the evidence supporting the use of CGM and AID in the various diabetes populations, discuss the current eligibility criteria that make these technologies inaccessible to individuals who would benefit, and present recommendations for modifying these criteria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin Infusion SystemsInsulinDiabetes MellitusHypoglycemic AgentsHealth Services AccessibilityDiabetes Mellitus, Type 1HumansContinuous Glucose MonitoringBlood Glucose Self-MonitoringBlood Glucose

Stichwörter der Autor:innen

AIDCGMautomated insulin deliverycontinuous glucose monitoringinsurance

Substanzen

InsulinHypoglycemic AgentsBlood Glucose

Autor:innen und Institutionen

  • Division of Endocrinology, Diabetes, Bone & Mineral, Henry Ford Health System, Detroit, MI, USA.
  • CGParkin Communications, Inc, Henderson, NV, USA.
  • School of Medicine, The University of Washington, Seattle, WA, USA.
  • Division of Endocrinology, Metabolism and Molecular Medicine, Feinberg School of Medicine, Northwestern University, Chicago IL, USA.
  • Division of Endocrinology, Metabolism and Lipid Research, School of Medicine, Washington University, St Louis, MO, USA.
  • Lennar Medical Center, UMiami Health System, Jackson Memorial Health System, Miller School of Medicine, University of Miami, Miami, FL, USA.

ORCID-Profile: Christopher G Parkin, Irl B Hirsch, Grazia Aleppo, Rodolfo J Galindo, Carol J Levy, Guillermo E Umpierrez, Richard M Bergenstal

Förderung

  • NIDDK NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Kruger, D. F., Parkin, C. G., Hirsch, I. B., Aleppo, G., McGill, J. B., Galindo, R. J., Levy, C. J., Umpierrez, G. E., Grunberger, G., & Bergenstal, R. M. (2026). Addressing the Diabetes Tsunami Requires Expanded Access to Diabetes Technologies. Journal of Diabetes Science and Technology. https://doi.org/10.1177/19322968251332956

Vancouver

Kruger DF, Parkin CG, Hirsch IB, Aleppo G, McGill JB, Galindo RJ, et al. Addressing the Diabetes Tsunami Requires Expanded Access to Diabetes Technologies. Journal of Diabetes Science and Technology. 2026. doi:10.1177/19322968251332956

BibTeX
@article{Kruger2026,
  author = {Kruger, Davida F and Parkin, Christopher G and Hirsch, Irl B and Aleppo, Grazia and McGill, Janet B and Galindo, Rodolfo J and Levy, Carol J and Umpierrez, Guillermo E and Grunberger, George and Bergenstal, Richard M},
  title = {Addressing the Diabetes Tsunami Requires Expanded Access to Diabetes Technologies},
  journal = {Journal of Diabetes Science and Technology},
  year = {2026},
  doi = {10.1177/19322968251332956}
}
Kostenlos starten →